FruitVaccine Inc develops orally administered fruit-based vaccines. With partiuclar targeted to different segments of the population: pills and puree - targeting children, adults and the elderly, and oral drops - especially targeting the infants. Focus is employing this approach against globally problematic infectious respiratory diseases. Using natural plants as the vaccine-factories, the firm's vaccines are non-invasive, safe, cost-effective, environmentally- and vegan-friendly as well as being an ideal choice for those who are allergic to egg-based vaccines. The firm's first vaccine is against human respiratory syncytial virus (hRSV), which causes flu-like symptoms affecting mainly the lower respiratory system, eg the lungs, and is the major cause of secondary infections including bronchiolitis and pneumonia. A second arena of focus is addressing vaccine goals target COVID-19 and other respiratory diseases.
